Brief: Rallybio Says Entered Amendment To Certain Sales Agreement
13/03/2025 21:35
March 13 (Reuters) - Rallybio Corp RLYB.O: RALLYBIO CORP -ENTERED AMENDMENT NO. 1 TO SALES AGREEMENT DATED AUGUST 8, 2022 RALLYBIO CORP - REDUCES STOCK SALE AMOUNT TO $9.55 MILLION Source text: [ID:n0001739410-25-000041] Further company coverage: RLYB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx